PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 224 filers reported holding PDL BIOPHARMA INC in Q2 2014. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $512,000 | -41.4% | 163,100 | -37.8% | 0.07% | -35.2% |
| Q1 2016 | $873,000 | +106.9% | 262,100 | +119.9% | 0.10% | +98.1% |
| Q4 2015 | $422,000 | -6.4% | 119,200 | +32.9% | 0.05% | -13.1% |
| Q3 2015 | $451,000 | -6.0% | 89,659 | +20.2% | 0.06% | -25.6% |
| Q2 2015 | $480,000 | -4.8% | 74,600 | +4.2% | 0.08% | -38.8% |
| Q1 2015 | $504,000 | +350.0% | 71,581 | +377.2% | 0.13% | +74.0% |
| Q3 2014 | $112,000 | -32.5% | 15,000 | -12.8% | 0.08% | -31.2% |
| Q2 2014 | $166,000 | – | 17,200 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |